MHRA updates guidance on the Health Institution Exemption to support safe use of medical devices
Updated MHRA guidance will help health institutions, such as NHS Trusts and Boards, safely design and make general medical devices for patients.
Updated MHRA guidance will help health institutions, such as NHS Trusts and Boards, safely design and make general medical devices for patients.
Information for manufacturers on the regulations that apply to prosthetic, orthotic and ophthalmic devices.
Guidance for health institutions that manufacture general medical devices under the Health Institution Exemption (HIE).
Exploring the MHRA’s transformational impact on access, experience, and outcomes.
Details and statistics on the import of unlicensed medicines from March 2014 onwards.
How to conform with the legal requirements for placing medical devices on the market.
As with any medicine, the MHRA will keep the safety and effectiveness of depemokimab under close review.
Professor Benger’s leadership comes at a pivotal time as the MHRA and NICE deepen collaboration
As with any medicine, the MHRA will keep the safety and effectiveness of fluticasone propionate under close review.
Details of the organisations that are currently approved to undertake conformity assessments on medical devices.
Activase Pharmaceuticals Limited is recalling two batches of Prednisolone 5mg Soluble Tablets as a precautionary measure due to a limited number of reports of blister pockets becoming swollen over time.
List of Field Safety Notices from 8-12 December 2025